These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27720388)

  • 21. Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia.
    Mizrahi R; Rusjan P; Agid O; Graff A; Mamo DC; Zipursky RB; Kapur S
    Am J Psychiatry; 2007 Apr; 164(4):630-7. PubMed ID: 17403977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schizophrenia model of elevated D2(High) receptors: haloperidol reverses the amphetamine-induced elevation in dopamine D2(High).
    Seeman P
    Schizophr Res; 2009 Apr; 109(1-3):191-2. PubMed ID: 19171464
    [No Abstract]   [Full Text] [Related]  

  • 23. Neurobiology of dopamine in schizophrenia.
    Guillin O; Abi-Dargham A; Laruelle M
    Int Rev Neurobiol; 2007; 78():1-39. PubMed ID: 17349856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Central dopaminergic receptors and negative symptoms in schizophrenia].
    Martinot JL; Paillere-Martinot ML; Loc'h C; Aubin F; Dao-Castellana MH; Deslauriers AG; Syrota A; Lecrubier Y
    Ann Med Psychol (Paris); 1992; 150(2-3):127-30. PubMed ID: 1343506
    [No Abstract]   [Full Text] [Related]  

  • 25. The dopamine hypothesis of schizophrenia: version III--the final common pathway.
    Howes OD; Kapur S
    Schizophr Bull; 2009 May; 35(3):549-62. PubMed ID: 19325164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Semi-mechanistic computer simulation of psychotic symptoms in schizophrenia with a model of a humanized cortico-striatal-thalamocortical loop.
    Spiros A; Roberts P; Geerts H
    Eur Neuropsychopharmacol; 2017 Feb; 27(2):107-119. PubMed ID: 28062203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.
    Ghisi V; Ramsey AJ; Masri B; Gainetdinov RR; Caron MG; Salahpour A
    Cell Signal; 2009 Jan; 21(1):87-94. PubMed ID: 18929645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia.
    Yang YK; Yeh TL; Chiu NT; Lee IH; Chen PS; Lee LC; Jeffries KJ
    Psychiatry Res; 2004 Sep; 131(3):209-16. PubMed ID: 15465290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using human brain imaging studies as a guide toward animal models of schizophrenia.
    Bolkan SS; Carvalho Poyraz F; Kellendonk C
    Neuroscience; 2016 May; 321():77-98. PubMed ID: 26037801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia.
    Kostrzewa RM; Nowak P; Brus R; Brown RW
    Neurochem Res; 2016 Feb; 41(1-2):183-92. PubMed ID: 26547196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients.
    Pickar D; Su TP; Weinberger DR; Coppola R; Malhotra AK; Knable MB; Lee KS; Gorey J; Bartko JJ; Breier A; Hsiao J
    Am J Psychiatry; 1996 Dec; 153(12):1571-8. PubMed ID: 8942453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline.
    Seeman P; Guan HC; Nobrega J; Jiwa D; Markstein R; Balk JH; Picetti R; Borrelli E; Van Tol HH
    Synapse; 1997 Feb; 25(2):137-46. PubMed ID: 9021894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.
    Kegeles LS; Slifstein M; Frankle WG; Xu X; Hackett E; Bae SA; Gonzales R; Kim JH; Alvarez B; Gil R; Laruelle M; Abi-Dargham A
    Neuropsychopharmacology; 2008 Dec; 33(13):3111-25. PubMed ID: 18418366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of prenatal immune challenge and restraint stress affects prepulse inhibition and dopaminergic/GABAergic markers.
    Deslauriers J; Larouche A; Sarret P; Grignon S
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():156-64. PubMed ID: 23697796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine A2a receptor/dopamine D2 receptor hetero-oligomerization: a hypothesis that may explain behavioral sensitization to psychostimulants and schizophrenia.
    Tsai SJ
    Med Hypotheses; 2005; 64(1):197-200. PubMed ID: 15533641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.
    Kellendonk C; Simpson EH; Polan HJ; Malleret G; Vronskaya S; Winiger V; Moore H; Kandel ER
    Neuron; 2006 Feb; 49(4):603-15. PubMed ID: 16476668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insights into clinical response in schizophrenia: from dopamine D2 receptor occupancy to patients' quality of life.
    Goff DC
    Am J Psychiatry; 2008 Aug; 165(8):940-3. PubMed ID: 18676595
    [No Abstract]   [Full Text] [Related]  

  • 40. Striatal dopamine receptor plasticity in neurotensin deficient mice.
    Chastain LG; Qu H; Bourke CH; Iuvone PM; Dobner PR; Nemeroff CB; Kinkead B
    Behav Brain Res; 2015 Mar; 280():160-71. PubMed ID: 25449842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.